393569-31-8,MFCD06411576
Catalog No.:AA00D5S0

393569-31-8 | SPLA2 INHIBITOR

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥95%
in stock  
$93.00   $65.00
- +
5mg
≥95%
in stock  
$380.00   $266.00
- +
10mg
≥95%
in stock  
$706.00   $494.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00D5S0
Chemical Name:
SPLA2 INHIBITOR
CAS Number:
393569-31-8
Molecular Formula:
C31H37NO4
Molecular Weight:
487.6298
MDL Number:
MFCD06411576
SMILES:
OC(=O)CC[C@@H](Cc1ccc(cc1)OCc1ccccc1)NC(=O)CCCCCCc1ccccc1
Properties
Computed Properties
 
Complexity:
604  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
36  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
16  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
6.8  

Literature

Title: An inhibitor of phospholipase A2 group IIA modulates adipocyte signaling and protects against diet-induced metabolic syndrome in rats.

Journal: Diabetes 20120901

Title: Secretory phospholipase A2 inhibition attenuates intercellular adhesion molecule-1 expression in human esophageal adenocarcinoma cells.

Journal: The Annals of thoracic surgery 20110501

Title: Comparative efficacy of a secretory phospholipase A2 inhibitor with conventional anti-inflammatory agents in a rat model of antigen-induced arthritis.

Journal: Arthritis research & therapy 20110101

Title: 1-(5-carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A(2)alpha with reduced lipophilicity: synthesis, biological activity, metabolic stability, solubility, bioavailability, and topical in vivo activity.

Journal: Journal of medicinal chemistry 20100722

Title: Modulation of growth in human esophageal adenocarcinoma cells by group IIa secretory phospholipase A(2).

Journal: The Journal of thoracic and cardiovascular surgery 20100301

Title: The use of live-animal micro-computed tomography to determine the effect of a novel phospholipase A2 inhibitor on alveolar bone loss in an in vivo mouse model of periodontitis.

Journal: Journal of periodontal research 20090601

Title: Inhibitors of cyclo-oxygenase-2 and secretory phospholipase A2 preserve bone architecture following ovariectomy in adult rats.

Journal: Bone 20060701

Title: Antifibrotic activity of an inhibitor of group IIA secretory phospholipase A2 in young spontaneously hypertensive rats.

Journal: Journal of immunology (Baltimore, Md. : 1950) 20060601

Title: A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induced colitis.

Journal: International immunopharmacology 20050501

Title: Comparative protection against rat intestinal reperfusion injury by a new inhibitor of sPLA2, COX-1 and COX-2 selective inhibitors, and an LTC4 receptor antagonist.

Journal: British journal of pharmacology 20030901

Title: D-Tyrosine as a chiral precusor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with antiinflammatory activity.

Journal: Chembiochem : a European journal of chemical biology 20030303

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 393569-31-8
Historical Records
Tags:393569-31-8 Molecular Formula|393569-31-8 MDL|393569-31-8 SMILES|393569-31-8 SPLA2 INHIBITOR
Catalog No.: AA00D5S0
393569-31-8,MFCD06411576
393569-31-8 | SPLA2 INHIBITOR
Pack Size: 1mg
Purity: ≥95%
in stock
$93.00 $65.00
Pack Size: 5mg
Purity: ≥95%
in stock
$380.00 $266.00
Pack Size: 10mg
Purity: ≥95%
in stock
$706.00 $494.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00D5S0
Chemical Name: SPLA2 INHIBITOR
CAS Number: 393569-31-8
Molecular Formula: C31H37NO4
Molecular Weight: 487.6298
MDL Number: MFCD06411576
SMILES: OC(=O)CC[C@@H](Cc1ccc(cc1)OCc1ccccc1)NC(=O)CCCCCCc1ccccc1
Properties
Complexity: 604  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 1  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 36  
Hydrogen Bond Acceptor Count: 4  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 16  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 6.8  
Literature fold

Title: An inhibitor of phospholipase A2 group IIA modulates adipocyte signaling and protects against diet-induced metabolic syndrome in rats.

Journal: Diabetes20120901

Title: Secretory phospholipase A2 inhibition attenuates intercellular adhesion molecule-1 expression in human esophageal adenocarcinoma cells.

Journal: The Annals of thoracic surgery20110501

Title: Comparative efficacy of a secretory phospholipase A2 inhibitor with conventional anti-inflammatory agents in a rat model of antigen-induced arthritis.

Journal: Arthritis research & therapy20110101

Title: 1-(5-carboxyindol-1-yl)propan-2-one inhibitors of human cytosolic phospholipase A(2)alpha with reduced lipophilicity: synthesis, biological activity, metabolic stability, solubility, bioavailability, and topical in vivo activity.

Journal: Journal of medicinal chemistry20100722

Title: Modulation of growth in human esophageal adenocarcinoma cells by group IIa secretory phospholipase A(2).

Journal: The Journal of thoracic and cardiovascular surgery20100301

Title: The use of live-animal micro-computed tomography to determine the effect of a novel phospholipase A2 inhibitor on alveolar bone loss in an in vivo mouse model of periodontitis.

Journal: Journal of periodontal research20090601

Title: Inhibitors of cyclo-oxygenase-2 and secretory phospholipase A2 preserve bone architecture following ovariectomy in adult rats.

Journal: Bone20060701

Title: Antifibrotic activity of an inhibitor of group IIA secretory phospholipase A2 in young spontaneously hypertensive rats.

Journal: Journal of immunology (Baltimore, Md. : 1950)20060601

Title: A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induced colitis.

Journal: International immunopharmacology20050501

Title: Comparative protection against rat intestinal reperfusion injury by a new inhibitor of sPLA2, COX-1 and COX-2 selective inhibitors, and an LTC4 receptor antagonist.

Journal: British journal of pharmacology20030901

Title: D-Tyrosine as a chiral precusor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with antiinflammatory activity.

Journal: Chembiochem : a European journal of chemical biology20030303

Building Blocks More >
42835-54-1
42835-54-1
1-Oxo-6,7-dihydro-1h,5h-pyrido[3,2,1-ij]quinoline-2-carboxylic acid
AA00D7BH | MFCD04054578
475272-54-9
475272-54-9
(S)-1-Boc-3-isopropyl-piperazine
AA00D7X9 | MFCD07772112
53911-68-5
53911-68-5
2H-Pyran-2,6(3H)-dione, 4-(4-chlorophenyl)dihydro-
AA00D80R | MFCD00190250
511272-48-3
511272-48-3
Fmoc-(r)-3-amino-3-(2-naphthyl)-propionic acid
AA00D86S | MFCD03428029
536693-95-5
536693-95-5
2-Chloro-6-methylpyridine-3-boronic acid
AA00D8BU | MFCD03411563
465514-37-8
465514-37-8
[1-(4-Fluorophenyl)-5-methyl-1h-pyrazol-4-yl]methanol
AA00D8FQ | MFCD03644148
55579-71-0
55579-71-0
5-(3-Chlorophenyl)cyclohexane-1,3-dione
AA00D8L5 | MFCD00111880
4664-55-5
4664-55-5
2-Phenoxyacetohydrazide
AA00D8RZ | MFCD00297030
51938-17-1
51938-17-1
N-NITROSO-N-METHYL-4-AMINOBUTYRIC ACID, METHYL ESTER
AA00D8XF | MFCD01320440
5331-42-0
5331-42-0
2-Cyano-3-phenylpropionic acid
AA00D934 | MFCD00205073
Submit
© 2017 AA BLOCKS, INC. All rights reserved.